Applied BioCode (6598.TW) Saham Harga

Applied BioCode Harga

TWSE·DITUTUP
30,20TWD+1,45 (+4,92 %)
Pasar ditutup

Revenue has compounded at 27,1% per year over the past 12 years to 475,20 Juta. TWD. Applied BioCode's net margin stands at -42,3%, up from -51,6% several years earlier. The stock trades about 57% above its 52-week low.

Harga saham Applied BioCode

Volume
Detail

Kurs

ⓘ

Tinjauan

Diagram kurs saham memberikan wawasan terperinci dan dinamis tentang kinerja saham Applied BioCode dan menampilkan harga yang teragregasi harian, mingguan atau bulanan. Pengguna dapat beralih antar kerangka waktu yang berbeda untuk menganalisis sejarah saham secara hati-hati dan mengambil keputusan investasi yang berbasis data.

Fungsi Intraday

Fungsi Intraday menyediakan data waktu nyata dan memungkinkan investor untuk melihat fluktuasi harga saham Applied BioCode selama hari perdagangan, agar dapat mengambil keputusan investasi yang tepat waktu dan strategis.

Total Return dan Perubahan Harga Relatif

Lihat total return dari saham Applied BioCode untuk menilai profitabilitasnya seiring waktu. Perubahan harga relatif, berdasarkan harga tersedia pertama dalam kerangka waktu yang dipilih, memberikan wawasan dalam kinerja saham dan membantu dalam mengevaluasi potensi investasinya.

Interpretasi dan Investasi

Gunakan data komprehensif yang disajikan dalam diagram kurs saham untuk menganalisis tren pasar, pergerakan harga, dan potensi return dari Applied BioCode. Ambil keputusan investasi yang berinformasi dengan membandingkan berbagai kerangka waktu dan mengevaluasi data intraday untuk manajemen portofolio yang dioptimalkan.

Applied BioCode Sejarah Kurs
TanggalApplied BioCode Harga
31/7/202630,20 TWD
30/7/202628,75 TWD
29/7/202629,85 TWD
28/7/202629,10 TWD
27/7/202630,00 TWD
24/7/202627,70 TWD
23/7/202628,80 TWD
22/7/202627,85 TWD
21/7/202626,65 TWD
20/7/202626,85 TWD
17/7/202627,65 TWD
16/7/202625,20 TWD
15/7/202626,15 TWD
14/7/202623,80 TWD
13/7/202624,80 TWD
10/7/202622,85 TWD
9/7/202622,85 TWD
8/7/202622,75 TWD
7/7/202622,95 TWD
6/7/202623,25 TWD
3/7/202623,05 TWD
2/7/202622,75 TWD
1/7/202622,50 TWD
30/6/202622,85 TWD
29/6/202622,85 TWD
26/6/202622,80 TWD
25/6/202622,90 TWD
24/6/202623,20 TWD
23/6/202623,45 TWD
22/6/202623,75 TWD
18/6/202624,15 TWD
17/6/202624,40 TWD
16/6/202624,40 TWD
15/6/202625,00 TWD
12/6/202624,60 TWD
11/6/202624,50 TWD
10/6/202624,90 TWD
9/6/202625,00 TWD
8/6/202624,50 TWD
5/6/202624,50 TWD
4/6/202624,50 TWD
3/6/202624,10 TWD
2/6/202624,30 TWD
1/6/202624,20 TWD
29/5/202624,75 TWD
28/5/202624,75 TWD
27/5/202624,95 TWD
26/5/202624,85 TWD
25/5/202624,50 TWD
22/5/202624,30 TWD
21/5/202624,30 TWD
20/5/202624,20 TWD
19/5/202624,65 TWD
18/5/202624,50 TWD
15/5/202624,35 TWD
14/5/202623,75 TWD
13/5/202624,15 TWD
12/5/202623,35 TWD
11/5/202622,70 TWD
8/5/202622,50 TWD
7/5/202622,60 TWD
6/5/202622,90 TWD
5/5/202622,55 TWD
4/5/202622,55 TWD
30/4/202621,45 TWD
29/4/202621,95 TWD
28/4/202621,90 TWD
27/4/202621,90 TWD
24/4/202621,95 TWD
23/4/202621,85 TWD
22/4/202622,15 TWD
21/4/202622,25 TWD
20/4/202622,70 TWD
17/4/202622,80 TWD
16/4/202622,90 TWD
15/4/202622,80 TWD
14/4/202622,60 TWD
13/4/202622,60 TWD
10/4/202622,00 TWD
9/4/202621,80 TWD
8/4/202622,80 TWD
7/4/202622,55 TWD
2/4/202623,10 TWD
1/4/202623,40 TWD
31/3/202622,65 TWD
30/3/202623,30 TWD
27/3/202623,35 TWD
26/3/202623,55 TWD
25/3/202624,15 TWD
24/3/202623,65 TWD
23/3/202624,25 TWD
20/3/202624,95 TWD
19/3/202625,00 TWD
18/3/202624,80 TWD
17/3/202624,60 TWD
16/3/202624,80 TWD
13/3/202625,05 TWD
12/3/202624,55 TWD
11/3/202625,30 TWD
10/3/202623,90 TWD
9/3/202623,60 TWD
6/3/202624,65 TWD
5/3/202624,50 TWD
26/2/202625,30 TWD
25/2/202624,55 TWD
24/2/202624,35 TWD
23/2/202624,50 TWD
11/2/202624,05 TWD
10/2/202624,05 TWD
9/2/202625,65 TWD
6/2/202623,35 TWD
5/2/202624,30 TWD
4/2/202624,40 TWD
3/2/202624,10 TWD
2/2/202623,60 TWD
30/1/202624,10 TWD
29/1/202624,05 TWD
28/1/202624,80 TWD
27/1/202624,15 TWD
26/1/202623,95 TWD
23/1/202623,60 TWD
22/1/202624,05 TWD
21/1/202623,45 TWD
20/1/202623,90 TWD
19/1/202624,50 TWD
16/1/202624,45 TWD
15/1/202624,60 TWD
13/1/202623,40 TWD
12/1/202624,25 TWD
9/1/202623,15 TWD
8/1/202623,05 TWD
7/1/202622,30 TWD
6/1/202622,40 TWD
5/1/202622,35 TWD
2/1/202622,00 TWD
31/12/202522,00 TWD
30/12/202522,00 TWD
29/12/202522,30 TWD
26/12/202522,05 TWD
24/12/202521,60 TWD
23/12/202522,00 TWD
22/12/202522,10 TWD
19/12/202521,50 TWD
18/12/202521,25 TWD
17/12/202521,10 TWD
16/12/202521,10 TWD
15/12/202521,25 TWD
12/12/202521,10 TWD
11/12/202521,40 TWD
10/12/202521,45 TWD
9/12/202521,30 TWD
8/12/202521,40 TWD
5/12/202521,55 TWD
4/12/202521,40 TWD
3/12/202521,65 TWD
2/12/202521,65 TWD
1/12/202521,75 TWD
28/11/202522,10 TWD
27/11/202521,70 TWD
26/11/202521,55 TWD
25/11/202521,35 TWD
24/11/202521,20 TWD
21/11/202521,20 TWD
20/11/202520,95 TWD
19/11/202520,55 TWD
18/11/202521,00 TWD
17/11/202521,00 TWD
14/11/202521,10 TWD
13/11/202521,25 TWD
12/11/202521,30 TWD
11/11/202521,85 TWD
10/11/202522,70 TWD
7/11/202523,10 TWD
6/11/202522,70 TWD
5/11/202522,70 TWD
4/11/202522,65 TWD
3/11/202522,80 TWD
31/10/202522,90 TWD
30/10/202523,00 TWD
29/10/202522,55 TWD
28/10/202523,05 TWD
27/10/202523,00 TWD
23/10/202523,10 TWD
22/10/202523,15 TWD
21/10/202523,00 TWD
20/10/202523,10 TWD
17/10/202523,00 TWD
16/10/202522,95 TWD
15/10/202522,85 TWD
14/10/202522,75 TWD
13/10/202523,00 TWD
9/10/202523,10 TWD
8/10/202522,70 TWD
7/10/202522,95 TWD
3/10/202522,55 TWD
2/10/202522,60 TWD
1/10/202523,30 TWD
30/9/202523,65 TWD
26/9/202523,60 TWD
25/9/202523,00 TWD
24/9/202522,65 TWD
23/9/202522,60 TWD
22/9/202522,45 TWD
19/9/202522,70 TWD
18/9/202522,95 TWD
17/9/202523,05 TWD
16/9/202523,10 TWD
15/9/202523,05 TWD
12/9/202523,15 TWD
11/9/202523,35 TWD
10/9/202523,35 TWD
9/9/202523,25 TWD
8/9/202521,40 TWD
5/9/202520,85 TWD
4/9/202522,00 TWD
3/9/202520,60 TWD
2/9/202519,70 TWD
1/9/202519,35 TWD
29/8/202519,60 TWD
28/8/202519,55 TWD
27/8/202519,55 TWD
26/8/202519,55 TWD
25/8/202519,60 TWD
22/8/202519,35 TWD
21/8/202519,35 TWD
20/8/202519,25 TWD
19/8/202519,30 TWD
18/8/202519,55 TWD
15/8/202519,55 TWD
14/8/202519,55 TWD
13/8/202519,50 TWD
12/8/202519,50 TWD
11/8/202519,50 TWD
8/8/202519,90 TWD
7/8/202520,00 TWD
6/8/202520,15 TWD
5/8/202520,05 TWD
4/8/202519,80 TWD
Access this data via the Eulerpool API
Get Free API Key

Pendapatan Applied BioCode, EBIT, Laba Bersih

  • 3 tahun

  • 5 tahun

  • 10 tahun

  • 25 Tahun

  • Maks

Pendapatan
EBIT
Laba Bersih
Details
Date
Pendapatan
EBIT
Laba Bersih
1 Jan 2019
104,69 Juta. TWD
-273,46 Juta. TWD
-280,07 Juta. TWD
1 Jan 2020
299,02 Juta. TWD
-99,16 Juta. TWD
-103,50 Juta. TWD
1 Jan 2021
319,96 Juta. TWD
-162,31 Juta. TWD
-165,20 Juta. TWD
1 Jan 2022
390,30 Juta. TWD
-181,93 Juta. TWD
-184,73 Juta. TWD
1 Jan 2023
395,17 Juta. TWD
-186,70 Juta. TWD
-164,20 Juta. TWD
1 Jan 2024
343,07 Juta. TWD
-277,67 Juta. TWD
-260,81 Juta. TWD
1 Jan 2025
475,20 Juta. TWD
-223,33 Juta. TWD
-201,20 Juta. TWD
1 Jan 2026 (e)
0,00 TWD
0,00 TWD
0,00 TWD

Applied BioCode Saham Kennzahlen

Terakhir diperbarui 3 Agu 2026, 13.48
 
OMSETJuta. TWD
PERTUMBUHAN PENDAPATAN%
MARGIN KOTOR%
PENDAPATAN KOTORJuta. TWD
EBITJuta. TWD
MARGIN EBIT%
LABA BERSIHJuta. TWD
PERTUMBUHAN LABA BERSIH%
JUMLAH SAHAMJuta.
20132014201520162017201820192020202120222023202420252026e
26,0015,0023,0011,0026,0037,00104,00299,00319,00390,00395,00343,00475,00–
–-42,3153,33-52,17136,3642,31181,08187,506,6922,261,28-13,1638,48–
7,6913,3326,0936,3630,7743,2450,0064,5559,2560,0067,8559,1854,74–
2,002,006,004,008,0016,0052,00193,00189,00234,00268,00203,00260,00260,00
-83,00-162,00-221,00-194,00-263,00-267,00-273,00-99,00-162,00-181,00-186,00-277,00-223,00–
-319,23-1.080,00-960,87-1.763,64-1.011,54-721,62-262,50-33,11-50,78-46,41-47,09-80,76-46,95–
-208,00-71,00-21,00-135,00-263,00-268,00-280,00-103,00-165,00-184,00-164,00-260,00-201,00–
–-65,87-70,42542,8694,811,904,48-63,2160,1911,52-10,8758,54-22,69–
102,65102,65102,6540,0546,6659,4271,1681,5981,7381,6981,77102,79102,65102,65
Detail

GuV

ⓘ

Pendapatan dan Pertumbuhan

Pendapatan Applied BioCode dan pertumbuhan pendapatan merupakan hal penting untuk pemahaman kesehatan finansial dan efisiensi operasional sebuah perusahaan. Peningkatan pendapatan yang konstan menunjukkan kemampuan perusahaan untuk memasarkan dan menjual produk atau jasanya secara efektif, sementara persentase pertumbuhan pendapatan memberikan gambaran tentang kecepatan pertumbuhan perusahaan dari tahun ke tahun.

Margin Bruto

Margin bruto adalah faktor penting yang menunjukkan persentase pendapatan yang melebihi biaya produksi. Margin bruto yang lebih tinggi menunjukkan efisiensi sebuah perusahaan dalam mengendalikan biaya produksinya serta menjanjikan potensi rentabilitas dan stabilitas finansial.

EBIT dan Margin EBIT

EBIT (Earnings Before Interest and Taxes) dan margin EBIT memberikan wawasan mendalam tentang rentabilitas sebuah perusahaan, tanpa memperhitungkan dampak dari bunga dan pajak. Investor sering menilai metrik ini untuk mengevaluasi efisiensi operasional dan rentabilitas yang inheren dari perusahaan, terlepas dari struktur keuangannya dan lingkungan perpajakannya.

Pendapatan dan Pertumbuhan

Pendapatan bersih dan pertumbuhan yang diikuti sangat penting bagi investor yang ingin memahami rentabilitas sebuah perusahaan. Pertumbuhan pendapatan yang konstan menegaskan kemampuan perusahaan untuk meningkatkan rentabilitasnya dari waktu ke waktu dan mencerminkan efisiensi operasional, daya saing strategis, dan kesehatan finansial.

Saham yang Beredar

Saham yang beredar merujuk pada jumlah total saham yang dikeluarkan oleh perusahaan. Ini penting untuk menghitung metrik utama seperti laba per saham (EPS), yang sangat penting bagi investor untuk mengevaluasi rentabilitas perusahaan berdasarkan per saham dan menyediakan gambaran yang lebih terinci tentang kesehatan finansial dan penilaian.

Interpretasi Perbandingan Tahunan

Membandingkan data tahunan memungkinkan investor untuk mengidentifikasi tren, mengevaluasi pertumbuhan perusahaan, dan memprediksi kinerja potensial di masa depan. Menganalisis bagaimana metrik seperti pendapatan, pendapatan, dan margin berubah dari tahun ke tahun dapat memberikan wawasan berharga tentang efisiensi operasional, daya saing, dan kesehatan finansial perusahaan.

Ekspektasi dan Prakiraan

Investor sering membandingkan data finansial saat ini dan masa lalu dengan ekspektasi pasar. Perbandingan ini membantu dalam menilai apakah kinerja Applied BioCode sesuai ekspektasi, di bawah rata-rata atau di atas rata-rata dan menyediakan data krusial untuk keputusan investasi.

Margin saham Applied BioCode

Analisis margin Applied BioCode menampilkan margin kotor, margin EBIT, serta margin laba dari Applied BioCode. Margin EBIT (EBIT/penjualan) menunjukkan persentase penjualan yang tersisa sebagai laba operasional. Margin laba menunjukkan persentase penjualan yang tersisa untuk Applied BioCode.

  • 3 tahun

  • 5 tahun

  • 10 tahun

  • 25 Tahun

  • Maks

Margin kotor
Margin EBIT
Margin laba
Details
Date
Margin kotor
Margin EBIT
Margin laba
1 Jan 2019
50,59 %
-261,20 %
-267,52 %
1 Jan 2020
64,72 %
-33,16 %
-34,61 %
1 Jan 2021
59,18 %
-50,73 %
-51,63 %
1 Jan 2022
60,00 %
-46,61 %
-47,33 %
1 Jan 2023
68,01 %
-47,25 %
-41,55 %
1 Jan 2024
59,46 %
-80,94 %
-76,02 %
1 Jan 2025
54,90 %
-47,00 %
-42,34 %
1 Jan 2026 (e)
54,90 %
0,00 %
0,00 %

Pendapatan Saham Applied BioCode, EBIT, Laba Per Saham

Pendapatan per saham Applied BioCode dengan demikian menunjukkan berapa banyak pendapatan yang telah dihasilkan Applied BioCode per saham dalam periode tertentu. Laba sebelum bunga dan pajak per saham menunjukkan berapa banyak laba operasional yang sesuai dengan setiap saham. Laba per saham menunjukkan berapa banyak laba yang dimiliki setiap saham.

  • 3 tahun

  • 5 tahun

  • 10 tahun

  • 25 Tahun

  • Maks

Pendapatan per Saham
EBIT per saham
Laba Per Saham
Details
Date
Pendapatan per Saham
EBIT per saham
Laba Per Saham
1 Jan 2019
1,47 TWD
-3,84 TWD
-3,94 TWD
1 Jan 2020
3,66 TWD
-1,22 TWD
-1,27 TWD
1 Jan 2021
3,91 TWD
-1,99 TWD
-2,02 TWD
1 Jan 2022
4,78 TWD
-2,23 TWD
-2,26 TWD
1 Jan 2023
4,83 TWD
-2,28 TWD
-2,01 TWD
1 Jan 2024
3,34 TWD
-2,70 TWD
-2,54 TWD
1 Jan 2025
4,63 TWD
-2,18 TWD
-1,96 TWD
1 Jan 2026 (e)
0,00 TWD
0,00 TWD
0,00 TWD

Model bisnis dan analisis saham Applied BioCode

Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice.

Penilaian Applied BioCode berdasarkan Fair Value

Detail

Estimasi Nilai Wajar

ⓘ

Apa Itu Nilai Wajar?

Nilai wajar adalah estimasi dari apa yang benar-benar "bernilai" dari saham berdasarkan fundamental keuangannya, terlepas dari harga pasar saat ini. Jika nilai wajar yang dihitung berada di atas harga saham saat ini, saham mungkin dinilai terlalu rendah — dan sebaliknya. Grafik ini menunjukkan tiga pendekatan nilai wajar yang berbeda sehingga Anda dapat saling memeriksa mereka.

Nilai Wajar Berbasis Laba

Dihitung dengan mengalikan laba per saham (EPS) saat ini dengan rata-rata rasio P/E historis selama periode multi-tahun yang dipilih. Perataan selama beberapa tahun menyaring lonjakan atau penurunan sementara. Jika nilai wajar ini melebihi harga pasar, ini menunjukkan bahwa saham murah relatif terhadap kekuatan penghasilannya.

Contoh: Nilai Wajar (Laba) 2022 = EPS 2022 × Rata-rata P/E 2019–2021

Nilai Wajar Berbasis Pendapatan

Diturunkan dengan mengalikan pendapatan per saham dengan rata-rata rasio harga-ke-penjualan historis. Metode ini sangat berguna untuk perusahaan dengan laba yang volatil atau sementara tertekan, karena pendapatan cenderung lebih stabil daripada laba. Ini menjawab: "Pada harga berapa pasar secara historis menilai setiap dolar penjualan perusahaan ini?"

Contoh: Nilai Wajar (Pendapatan) 2022 = Pendapatan per Saham 2022 × Rata-rata P/S 2019–2021

Nilai Wajar Berbasis Dividen

Dihitung dengan membagi dividen per saham dengan rata-rata hasil dividen historis. Pendekatan ini paling relevan untuk perusahaan matang yang secara konsisten membayar dividen. Jika nilai wajar yang dihasilkan lebih tinggi dari harga saat ini, ini menyiratkan bahwa saham menawarkan hasil yang lebih baik daripada rata-rata historisnya.

Contoh: Nilai Wajar (Dividen) 2022 = Dividen per Saham 2022 ÷ Rata-rata Hasil 2019–2021

Cara Menggunakan Grafik Ini

Ketika ketiga garis nilai wajar bertemu di atas harga saat ini, ini memperkuat kasus bahwa saham dinilai terlalu rendah. Ketika mereka divergen, selidiki mengapa — ini mungkin menunjukkan perubahan struktural dalam margin, kebijakan pembayaran, atau tingkat pertumbuhan. Estimasi maju di sisi kanan memperluas analisis menggunakan fundamental yang diproyeksikan, membantu Anda menilai apakah harga saat ini sudah mencerminkan harapan pertumbuhan masa depan.

Penilaian Applied BioCode berdasarkan PER historis, EBIT multiple, dan PSR

Pengembalian tahunan Applied BioCode

Detail

Pengembalian Tahunan

ⓘ

Apa yang Grafik Ini Tunjukkan

Grafik ini memecah pengembalian tahunan total menjadi dua komponen: pengembalian harga (keuntungan atau kerugian dari pergerakan harga saham) dan pengembalian dividen (pendapatan yang diterima dari pembayaran dividen). Bersama-sama, mereka mewakili total pengembalian yang akan diperoleh investor di setiap tahun kalender.

Pengembalian Harga

Pengembalian harga mengukur perubahan persentase dalam harga saham dari 1 Januari hingga 31 Desember setiap tahun. Batang positif menunjukkan saham dihargai; batang negatif menunjukkan penurunan. Ini adalah komponen yang paling difokuskan oleh investor, tetapi itu hanya menceritakan sebagian dari cerita — terutama untuk saham pembayar dividen.

Pengembalian Dividen

Pengembalian dividen mewakili pendapatan yang dihasilkan dari dividen yang dibayarkan selama tahun tersebut, dinyatakan sebagai persentase dari harga saham awal. Meskipun mungkin tampak kecil dalam satu tahun apa pun (biasanya 1–4% untuk perusahaan yang sudah mapan), dividen menggabungkan secara signifikan selama beberapa dekade dan secara historis telah berkontribusi sekitar 40% dari total pengembalian pasar saham.

Apa yang Perlu Dicari

Periksa berapa banyak tahun yang menunjukkan pengembalian positif vs. negatif untuk mengukur konsistensi. Saham dengan sebagian besar tahun positif dan drawdown kecil menunjukkan risiko yang lebih rendah. Juga bandingkan pengembalian tahunan dengan indeks benchmark — secara konsisten melampaui pasar adalah ciri investasi yang kuat. Perhatikan tahun-tahun terburuk: memahami risiko penurunan sama pentingnya dengan mengejar potensi naik.

Saham beredar Applied BioCode

Jumlah saham Applied BioCode pada tahun 2025 adalah 102,65 Juta.. Ini menunjukkan menjadi berapa banyak saham Applied BioCode dibagi. Karena pemegang saham adalah pemilik perusahaan, setiap saham mewakili sebagian kecil dari kepemilikan perusahaan.

  • 3 tahun

  • 5 tahun

  • 10 tahun

  • 25 Tahun

  • Maks

Jumlah saham
Details
Date
Jumlah saham
1 Jan 2019
71,16 Juta. Saham
1 Jan 2020
81,59 Juta. Saham
1 Jan 2021
81,73 Juta. Saham
1 Jan 2022
81,69 Juta. Saham
1 Jan 2023
81,77 Juta. Saham
1 Jan 2024
102,79 Juta. Saham
1 Jan 2025
102,65 Juta. Saham
1 Jan 2026 (e)
102,65 Juta. Saham
Target harga dan prakiraan untuk Applied BioCode saat ini tidak tersedia.

Struktur pemegang saham Applied BioCode

% Nama
9,73018%
Hsu (Fu-Lung)
Hsu (Fu-Lung)
9,16736%
Maxwell Sensors Incorporation
Maxwell Sensors Incorporation
3,94085%
Eureka BioVenture Partners
Eureka BioVenture Partners
3,06682%
GVT Fund L.P.
GVT Fund L.P.
3,01164%
Celerus Diagnostics
Celerus Diagnostics
2,48303%
Cathay Venture Inc.
Cathay Venture Inc.

Applied BioCode Beneficial Ownership Filings (SEC 13D/G)

Free Float
69,4%
Float Shares
-
Shares Outstanding
-

Applied BioCode Dewan Direksi dan Dewan Komisaris

14 members · 0 % women

Management

ZH

Mr. Zohn-Zen Ho

Founder, Chief Technology Officer, General Manager, Director · sejak 2008

–
LH

Mr. Liang-Kai Huang

Chief Financial Officer, Corporate Governance Officer

–
MA

Mr. Michael Aye

Vice President-Molecular Products

–
DW

Mr. Donald Wong

Vice President-Productions

–
YC

Mr. Youning Chen

Deputy General Manager-Taiwan Sub-Subsidiary

–
GK

Gerald Kowalski

Deputy General Manager-Operation

–

Board of Directors

JL

Mr. Jia-Long Lee

Chairman of the Board · sejak 2016

–
BJ

Mr. Benjamin Jen

Director

–
LL

Lizzie Lee

Director

–
WT

Mr. Wen-Jing Tsai

Independent Director

–
JT

James Tsu

Independent Director

–
JW

Jim Wu

Independent Director

–

Pertanyaan yang sering diajukan tentang saham Applied BioCode

The business model of Applied BioCode Corp is centered around providing innovative molecular diagnostics solutions. They specialize in the development, manufacture, and commercialization of barcode technology-based multiplex testing systems for diagnostics laboratories. With their proprietary BioCode-1000 system, they offer a cost-effective and scalable solution for high-throughput testing of various diseases such as cancer, infectious diseases, and genetic disorders. Applied BioCode Corp aims to improve patient outcomes by delivering accurate and timely diagnostic results to healthcare professionals. Their advanced technology, coupled with a commitment to continuous innovation, positions them as a leading player in the field of molecular diagnostics.

Applied BioCode Corp is primarily active in the biotechnology industry.

The main competitors of Applied BioCode Corp in the market include companies such as Illumina, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, and QIAGEN.

Applied BioCode Corp is a leading biotechnology company specializing in developing and commercializing molecular diagnostic systems. Founded in [insert year], Applied BioCode Corp has a rich history in the field of biotech and has consistently delivered innovative solutions for healthcare professionals. The company is dedicated to improving patient care by revolutionizing diagnostic testing through its proprietary barcoded magnetic bead technology. With a team of highly skilled scientists and engineers, Applied BioCode Corp has gained recognition for its advanced diagnostic platforms that offer high throughput, multiplex capability, and cost-effectiveness. The company continues to expand its product portfolio and collaborate with industry partners to address the evolving needs of the healthcare industry.

Applied BioCode Corp has achieved several significant milestones in its journey. The company has made strides in the development and commercialization of its proprietary Barcoded Magnetic Bead (BMB) technology. This innovative technology offers multiplex testing capabilities, enabling simultaneous analysis of multiple targets, including genes, proteins, and pathogens. Applied BioCode Corp has successfully launched its FDA-cleared BioCode MDx 3000 system, which allows complex diagnostic testing with high precision and speed. Additionally, the company has secured strategic partnerships and collaborations with major healthcare institutions, facilitating the adoption of its BMB technology. Through these achievements, Applied BioCode Corp has established itself as a leader in the field of molecular diagnostics.

Applied BioCode Corp is primarily present in the United States, particularly in the state of California.

Applied BioCode Corp is a prominent biotechnology company that values innovation, integrity, and excellence. With a strong corporate philosophy, Applied BioCode Corp focuses on developing cutting-edge technologies and solutions to revolutionize diagnostics and improve patient care. By merging the fields of molecular diagnostics and multiplex biomarker detection, the company aims to address unmet clinical needs. Applied BioCode Corp is committed to providing accurate and efficient diagnostic products that empower healthcare professionals and ultimately enhance patient outcomes. With its forward-thinking approach and commitment to quality, Applied BioCode Corp strives to contribute to the advancement of healthcare and improve global health outcomes.

9 analysts currently rate the Applied BioCode stock: 0 recommend buying, 3 holding and 6 selling.

Applied BioCode Target Harga Analis 2026

Converted at the current exchange rate, the Applied BioCode share trades at 0,81 EUR (30,20 TWD).

Applied BioCode Corp is a leading company in the field of molecular diagnostics and the development of digitally encoded barcode assays using multiple microbeads. The company utilizes its proprietary barcodes to enable complex biochemical analysis with high accuracy, reliability, and throughput capacity. The business model of Applied BioCode Corp is based on the development and commercialization of diagnostic systems and products for food and water analysis, clinical diagnostics, and research. The company offers innovative solutions to meet the needs of customers in various industries. Applied BioCode Corp's main division is the BioCode Gastrointestinal Pathogen Panel (GPP) diagnostic system, which allows for rapid and accurate diagnosis of gastrointestinal tract infections by simultaneously analyzing multiple samples for different bacteria, viruses, and parasites. Another product of the company is the BioCode Respiratory Pathogen Panel (RPP) system, which enables rapid and accurate diagnosis of respiratory infections by simultaneously analyzing multiple samples for different viruses and bacteria. The RPP provides an effective method for prevention, containment, and control of infectious diseases. Applied BioCode Corp also produces labeling products such as BioCode screening platforms to enable customers to accurately and timely identify pathogens. The company also offers a wide range of sampling methods and accessories to meet the requirements of diverse customers and applications. Applied BioCode Corp's products are distributed worldwide and are used in various industries, such as food and water analysis, clinical diagnostics, and research. The company focuses on offering innovative solutions to its customers to help meet their needs in terms of analysis, diagnosis, and results. Applied BioCode Corp also operates partnerships and collaborations with other companies to introduce and further develop its systems and products in new areas. The company is constantly striving to improve the quality and accuracy of its products while reducing costs to ensure high customer satisfaction. In conclusion, Applied BioCode Corp is a company that specializes in the development and commercialization of innovative diagnostic systems and products for food and water analysis, clinical diagnostics, and research. It offers its customers accurate and reliable solutions to meet their requirements and enhance their efficiency. With an advanced product portfolio, global trade partners, and a dedicated team of professionals, Applied BioCode Corp is undoubtedly one of the leading companies in the field of molecular diagnostics. Applied BioCode Corp is a leading company specializing in molecular diagnostics and the development of digitally encoded barcode assays using multiple microbeads. The company utilizes its proprietary barcodes to enable highly accurate, reliable, and high-throughput complex biochemical analyses. Their business model focuses on developing and marketing diagnostic systems and products for food and water analysis, clinical diagnostics, and research. They offer innovative solutions to meet the needs of customers in various industries. One of their main divisions is the BioCode Gastrointestinal Pathogen Panel (GPP) diagnostic system, which allows for rapid and accurate diagnosis of gastrointestinal infections by simultaneously analyzing multiple samples for various bacteria, viruses, and parasites. Another product is the BioCode Respiratory Pathogen Panel (RPP) system, providing fast and accurate diagnosis of respiratory infections by simultaneously analyzing multiple samples for different viruses and bacteria. The RPP offers an effective method for prevention, containment, and control of infectious diseases. Applied BioCode Corp also manufactures labeling products such as BioCode screening platforms, allowing for precise and timely identification of pathogens. They also offer a wide range of sampling methods and accessories to fulfill the requirements of different customers and applications. Their products are distributed worldwide and utilized in various industries including food and water analysis, clinical diagnostics, and research. The company focuses on providing customers with innovative solutions to fulfill their analytical, diagnostic, and result-related needs. They also engage in partnerships and collaborations with other companies to introduce and advance their systems and products in new areas. Applied BioCode Corp is committed to continuously improving the quality and accuracy of their products while reducing costs to ensure high customer satisfaction. In conclusion, Applied BioCode Corp is a specialized company that develops and markets innovative diagnostic systems and products for food and water analysis, clinical diagnostics, and research. Their accurate and reliable solutions help customers meet their requirements and increase efficiency. With their advanced product portfolio, global trade partnerships, and dedicated professional team, Applied BioCode Corp is a leading company in the field of molecular diagnostics.

Pendapatan tidak dapat dihitung untuk Applied BioCode saat ini.

Laba tidak dapat dihitung untuk Applied BioCode saat ini.

PER tidak dapat dihitung untuk Applied BioCode saat ini.

PSR tidak dapat dihitung untuk Applied BioCode saat ini.

Skor Kualitas AlleAktien untuk Applied BioCode adalah 4/10.

ISIN dari Applied BioCode adalah KYG0488D1051. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.

Ticker dari Applied BioCode adalah 6598.TW. Simbol ticker digunakan untuk memperdagangkan saham Applied BioCode di bursa saham.

Applied BioCode membayar dividen setiap tahun dalam 0 tahun terakhir.

Applied BioCode dikelompokkan dalam sektor 'Kesehatan'.

Dividen dari Applied BioCode dibayarkan dalam TWD.

Semua metrik fundamental dan analisis mendalam Applied BioCode

Analisis saham kami untuk saham Applied BioCode mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Applied BioCode. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.

Applied BioCode Saham
Applied BioCode Pendapatan→
Applied BioCode Saham
Applied BioCode Keuntungan→
Applied BioCode Saham
Applied BioCode PER→
Applied BioCode Saham
Applied BioCode P/S→
Applied BioCode Saham
Applied BioCode EBIT→
Applied BioCode Saham
Applied BioCode Dividen→
Applied BioCode Saham
Applied BioCode Pembelian Insider→
Applied BioCode Saham
Applied BioCode Saham→
Applied BioCode Saham
Applied BioCode Kapitalisasi Pasar→
Applied BioCode Saham
Applied BioCode Utang→
Applied BioCode Saham
Applied BioCode Utang→
Applied BioCode Saham
Applied BioCode Modal sendiri→
Applied BioCode Saham
Applied BioCode AAQS→
Applied BioCode Saham
Applied BioCode Karyawan→
Applied BioCode Saham
Applied BioCode ROE→
Applied BioCode Saham
Applied BioCode ROA→
Applied BioCode Saham
Applied BioCode ROCE→
Applied BioCode Saham
Applied BioCode News→
Applied BioCode Saham
Applied BioCode Target Harga Analis→

Kesehatan Saham

Applied BiosciencesAppili TherapeuticsAprea TherapeuticsApollomicsAprilBio CoApollo Hospitals EnterpriseAprogen BiologicsAPOLLO BioWellnessAPT MedicalApogee TherapeuticsAptaBio TherapeuticsApimeds Pharmaceuticals USSemua Saham A–Z →